A Further Study of the Toxicity of Pyrimethamine (Daraprim) in Man

A. V. Myatt Laboratory of Tropical Diseases, National Microbiological Institute, National Institutes of Health, Bethesda 14, Maryland

Search for other papers by A. V. Myatt in
Current site
Google Scholar
PubMed Close
,
G. Robert Coatney Laboratory of Tropical Diseases, National Microbiological Institute, National Institutes of Health, Bethesda 14, Maryland

Search for other papers by G. Robert Coatney in
Current site
Google Scholar
PubMed Close
,
Thomas Hernandez Laboratory of Tropical Diseases, National Microbiological Institute, National Institutes of Health, Bethesda 14, Maryland

Search for other papers by Thomas Hernandez in
Current site
Google Scholar
PubMed Close
, and
Herbert W. Burton Laboratory of Tropical Diseases, National Microbiological Institute, National Institutes of Health, Bethesda 14, Maryland

Search for other papers by Herbert W. Burton in
Current site
Google Scholar
PubMed Close
DOI:
https://doi.org/10.4269/ajtmh.1953.2.1000
Volume/Issue:
Volume 2: Issue 6
Page(s):
1000–1001
Restricted access
Get Permissions

Summary and Conclusions

Reported therapeutic tests show that pyrimethamine is an effective suppressant for malaria in dosage of 25 mg. single dose weekly. Our studies reported here and previously (Coatney et al., 1953) indicate that this dosage may be given safely to white or colored races without untoward reactions, barring possible cases of idiosyncrasy.
Published Online:
Nov 1953
Cover The American Journal of Tropical Medicine and Hygiene
The American Journal of Tropical Medicine and Hygiene
Print ISSN:
0002-9637
Past two years Past Year Past 30 Days
Abstract Views 91 55 3
Full Text Views 1 0 0
PDF Downloads 3 0 0
 
Membership Banner
 
 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save